Co-delivery of docetaxel and Poloxamer 235 by PLGA–TPGS nanoparticles for breast cancer treatment

Grobmyer, 2012, Nanoparticle delivery for metastatic breast cancer, Nanomedicine, S21, 10.1016/j.nano.2012.05.011 Zhu, 2014, Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance, Biomaterials, 35, 2391, 10.1016/j.biomaterials.2013.11.086 Zhang, 2010, A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment, Acta Biomater., 6, 2045, 10.1016/j.actbio.2009.11.035 Yan, 2010, The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity, Nanomedicine, 6, 170, 10.1016/j.nano.2009.05.004 Devalapally, 2007, Docetaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer, Int. J. Cancer, 121, 1830, 10.1002/ijc.22886 Onyuksel, 2009, Nanomicellar docetaxel increases cytotoxicity of multidrug resistant breast cancer cells, Cancer Lett., 274, 327, 10.1016/j.canlet.2008.09.041 Muthu, 2014, Nanotheranostics — application and further development of nanomedicine strategies for advanced theranostics, Theranostics, 4, 660, 10.7150/thno.8698 Mei, 2013, Pharmaceutical nanotechnology for oral delivery of anticancer drugs, Adv. Drug Deliv. Rev., 65, 880, 10.1016/j.addr.2012.11.005 Zhang, 2013, Paclitaxel drug delivery systems, Expert Opin. Drug Deliv., 10, 325, 10.1517/17425247.2013.752354 Abdelwahed, 2006, Freeze-drying of nanoparticles: formulation, process and storage considerations, Adv. Drug Deliv. Rev., 58, 1688, 10.1016/j.addr.2006.09.017 Ma, 2010, Nanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment, Nanoscale Res. Lett., 5, 1161, 10.1007/s11671-010-9620-3 Constantinou, 2008, Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs, Int. J. Cancer, 123, 739, 10.1002/ijc.23689 Moghimi, 2000, Poloxamers and poloxamines in nanoparticle engineering and experimental medicine, Trends Biotechnol., 18, 412, 10.1016/S0167-7799(00)01485-2 Kabanov, 2002, Pluronic block copolymers for overcoming drug resistance in cancer, Adv. Drug Deliv. Rev., 54, 759, 10.1016/S0169-409X(02)00047-9 Batrakova, 2008, Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers, J. Control. Release, 130, 98, 10.1016/j.jconrel.2008.04.013 Huang, 2008, Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism, Int. J. Pharm., 356, 351, 10.1016/j.ijpharm.2007.12.028 Zeng, 2014, Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer, Biomaterials, 34, 6058, 10.1016/j.biomaterials.2013.04.052 Zhang, 2014, The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment, Biomaterials, 35, 1932, 10.1016/j.biomaterials.2013.10.034 Tao, 2013, Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA–TPGS diblock copolymer for breast cancer therapy, Acta Biomater., 9, 8910, 10.1016/j.actbio.2013.06.034 Brown, 2004, Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells, Breast Cancer Res., 6, R601, 10.1186/bcr918 Reich, 1997, In vitro stability of poly(D, L-lactide) and poly(D, L-lactide)/poloxamer nanoparticles in gastrointestinal fluids, Drug Dev. Ind. Pharm., 23, 1191, 10.3109/03639049709146156 Storm, 1995, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system, Adv. Drug Deliv. Rev., 16, 31, 10.1016/0169-409X(95)00039-A Moghimi, 1993, Coating particles with block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim. Biophys. Acta, 1179, 157, 10.1016/0167-4889(93)90137-E Li, 1996, Plasma protein interactions with Pluronic treated colloids, Colloids Surf. B Biointerfaces, 7, 9, 10.1016/0927-7765(96)01269-6 Gref, 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Adv. Drug Deliv. Rev., 16, 215, 10.1016/0169-409X(95)00026-4 Wang, 2014, Antitumor efficiency of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in nice bearing cervical cancer, J. Biomed. Nanotechnol., 10, 1509, 10.1166/jbn.2014.1844 Sun, 2006, The in vivo degradation, absorption and excretion of PCL-based implant, Biomaterials, 27, 1735, 10.1016/j.biomaterials.2005.09.019 Jin, 2007, Radiosensitization of docetaxel, etanidazole and docetaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro, Biomaterials, 28, 3724, 10.1016/j.biomaterials.2007.04.032 Tao, 2014, Synthesis of cholic acid-core poly(ε-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment, Biomater. Sci., 2, 1262, 10.1039/C4BM00134F Qaddoumi, 2004, The characteristic and mechanisms of PLGA nanoparticles in rabbit conjunctival epithelial cell layers, Pharm. Res., 21, 641, 10.1023/B:PHAM.0000022411.47059.76 Desai, 1997, The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent, Pharm. Res., 14, 1568, 10.1023/A:1012126301290 Rejman, 2004, Size-dependent internalization of particle via the pathways of clathrin- and caveolae-mediated endocytosis, Biochem. J., 377, 159, 10.1042/bj20031253 Yang, 2008, Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA, Bioconjug. Chem., 19, 1987, 10.1021/bc800144a Mutoh, 2006, Estrogen-mediated post transcriptional downregulation of P-glycoprotein in MDR1-transduced human breast cancer cells, Cancer Sci., 97, 1198, 10.1111/j.1349-7006.2006.00300.x Borst, 2000, A family of drug transporters: the multidrug resistance-associated proteins, J. Natl. Cancer Inst., 92, 1295, 10.1093/jnci/92.16.1295 Almquist, 1995, Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell, Cancer Res., 55, 102 Hopper-Borge, 2004, Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel, Cancer Res., 64, 4927, 10.1158/0008-5472.CAN-03-3111 Li, 2013, Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines, Mol. Biol. Rep., 40, 6143, 10.1007/s11033-013-2725-x Wang, 2012, Star-like-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance, Biomaterials, 33, 6877, 10.1016/j.biomaterials.2012.06.019 Zhang, 2014, The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug, Biomaterials, 35, 9144, 10.1016/j.biomaterials.2014.07.028 Mei, 2014, Star-shaped block polymers as a molecular biomaterial for nanomedicine development, Nanomedicine, 9, 9, 10.2217/nnm.13.180 Zeng, 2014, Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA-b-TPGS for cancer treatment, Part. Part. Syst. Charact. Zhang, 2014, Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer, Theranostics, 4, 1085, 10.7150/thno.9933